Last week’s Five Favorites for Friday post ran a little heavy, with a focus on five different issues and articles concerning the Department of Labor’s new proposed regulation intended to somehow reduce class action litigation and increase participants’ exposure to alternative investments all at the same time. That seems like a trick worthy of Penn
I am going with a special edition of the Five Favorites post this week, solely covering five stories about the Department of Labor’s new proposed regulation addressing the issue of adding alternative assets, such as private equity and crypto, to the investments offered in 401(k) plans. For each one, I have included my own questions
I found myself feeling very zen and mellow when writing this week’s Five Favorites for Friday post. That’s not always the case, as often the post covers topics that get me quite agitated, such as articles about poorly reasoned court decisions or about unnecessary risks to plan participants. That wasn’t the case this week and
It’s been a fascinating week in insurance and ERISA news, making it a good week to be the author of an ongoing weekly series on hot topics, articles, posts and the like in these areas of law. Interestingly (to me, anyway), the first three stories directly concern cases and issues I have litigated many times
Some weeks the Five Favorites write themselves and this week was one of them. I think it’s because so many of the articles hit right dead center on issues I have litigated or counseled on over the years, including disputes between excess and primary insurers, whether forfeiture under a 401(k) plan is appropriate, withdrawal liability
This is a really educational week on Five Favorites for Friday. There is no hidden message or implicit critique buried in that point. It’s just that a number of comprehensive stories providing a detailed overview of key areas of development in ERISA litigation were published this past week and, solely because of their quality, make
This was a fun week if, like me, you enjoy reading about ERISA and insurance issues. There was a lot to pay attention to, but for purposes of this weekly post, I narrowed it down to articles on nuclear verdicts, cyber insurance, regulatory initiatives targeted at PBMs and drug pricing, the continued boom in ERISA